- Home
- BRX vs ROIV Comparison
BRX vs ROIV Comparison
Compare BRX & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | ROIV |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 14.1B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRX | ROIV |
|---|---|---|
| Price | $26.39 | $22.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $29.82 | $24.31 |
| AVG Volume (30 Days) | 3.1M | ★ 8.4M |
| Earning Date | 02-09-2026 | 02-09-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $1,346,289,000.00 | $20,329,000.00 |
| Revenue This Year | $7.62 | N/A |
| Revenue Next Year | $4.41 | $741.42 |
| P/E Ratio | $24.17 | ★ N/A |
| Revenue Growth | ★ 5.75 | N/A |
| 52 Week Low | $22.29 | $8.73 |
| 52 Week High | $28.61 | $23.47 |
Technical Indicators
Market Signals| Indicator | BRX | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 57.01 | 61.92 |
| Support Level | $25.58 | $21.60 |
| Resistance Level | $26.19 | $22.76 |
| Average True Range (ATR) | 0.41 | 0.84 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 97.44 | 73.46 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.